Time made all the difference in the world
... might never had survived, more than 70 families, who today might not have their loved one, their parent, their spouse or their child, had it not been for them. Their patients come from every area of the Hudson Valley and beyond and represent every walk of life, every socioeconomic demographic and ev ...
... might never had survived, more than 70 families, who today might not have their loved one, their parent, their spouse or their child, had it not been for them. Their patients come from every area of the Hudson Valley and beyond and represent every walk of life, every socioeconomic demographic and ev ...
An MRI Comparison of Quantitative Left Ventricular Structure
... resulted from difficulties in delineating the endocardial borders of the often highly fragmented myocardium at each cardiac phase. The reason for the elevated LVM CoR in the LVH cohort is less obvious, although may have been in part due to poor differentiation of hypertrophic myocardial borders and ...
... resulted from difficulties in delineating the endocardial borders of the often highly fragmented myocardium at each cardiac phase. The reason for the elevated LVM CoR in the LVH cohort is less obvious, although may have been in part due to poor differentiation of hypertrophic myocardial borders and ...
Managing Metallic Artifacts in MRI
... The SureScan pacing systems are contraindicated for implantation with unipolar pacing leads (Revo MRI™ only), concomitant implantation with another bradycardia device or an implantable cardioverter defibrillator. Dual chamber sequential pacing is contraindicated in patients with chronic or persisten ...
... The SureScan pacing systems are contraindicated for implantation with unipolar pacing leads (Revo MRI™ only), concomitant implantation with another bradycardia device or an implantable cardioverter defibrillator. Dual chamber sequential pacing is contraindicated in patients with chronic or persisten ...
Allocation Criteria for Heart, Lung and Heart-Lung
... Lost to follow-up Transplant done Death 4. At any time one patient can register only with one transplantation center. In case he/she wants to shift to some other center, they need to deregister with first center and then only register with second center. There should be at least 72 hours of ga ...
... Lost to follow-up Transplant done Death 4. At any time one patient can register only with one transplantation center. In case he/she wants to shift to some other center, they need to deregister with first center and then only register with second center. There should be at least 72 hours of ga ...
hypertrophic obstructive cardiomyopathy
... Al c o h o l S e p ta l A blat i on In some cases, a minimally invasive technique known as alcohol septal ablation may be used. This is a cardiac catheterization procedure. In this procedure, thin tubes known as catheters are inserted into the major vessels in the groin area and threaded up to the h ...
... Al c o h o l S e p ta l A blat i on In some cases, a minimally invasive technique known as alcohol septal ablation may be used. This is a cardiac catheterization procedure. In this procedure, thin tubes known as catheters are inserted into the major vessels in the groin area and threaded up to the h ...
Pregnancy outcomes in patients with pulmonary arterial
... and three were induced for fetal indication (severe SGA). There was no neonatal death in our series. Among the offsprings, two cardiac anomalies were diagnosed (11%): one VSD and one pulmonary valve stenosis associated with an ASD. All cases were confirmed by postnatal echocardiography. No additional ...
... and three were induced for fetal indication (severe SGA). There was no neonatal death in our series. Among the offsprings, two cardiac anomalies were diagnosed (11%): one VSD and one pulmonary valve stenosis associated with an ASD. All cases were confirmed by postnatal echocardiography. No additional ...
7-Days Holter
... non-permanent AF in China. After providing informed consent, patients will be randomly assigned to one of four groups（the valsartan group, the fluvastatin plus dihydropyridine CCBs group, the valsartan plus fluvastatin group, and the dihydropyridine CCBs group）by the School of Public Health of Tianj ...
... non-permanent AF in China. After providing informed consent, patients will be randomly assigned to one of four groups（the valsartan group, the fluvastatin plus dihydropyridine CCBs group, the valsartan plus fluvastatin group, and the dihydropyridine CCBs group）by the School of Public Health of Tianj ...
Age-related normal structural and functional ventricular values in
... majority of echocardiography and CMR studies, the findings with regard to LV mass seem more controversial. In some studies, LV mass was unchanged during aging [12] while in other studies an increase was found [14,18,19]. Interestingly, there was no association between age and LV mass in the Framingh ...
... majority of echocardiography and CMR studies, the findings with regard to LV mass seem more controversial. In some studies, LV mass was unchanged during aging [12] while in other studies an increase was found [14,18,19]. Interestingly, there was no association between age and LV mass in the Framingh ...
Lobster Heart Lab Protocol
... inside dorsal surface of this bag is the cardiac ganglion. It is a Y-shaped structure, about 1 cm long, with 9 nerve cells (7 strung along the stem, one in each arm of the Y). This ganglion is a mininervous system, functioning on its own, with stretch receptors responsive to filling of the heart tha ...
... inside dorsal surface of this bag is the cardiac ganglion. It is a Y-shaped structure, about 1 cm long, with 9 nerve cells (7 strung along the stem, one in each arm of the Y). This ganglion is a mininervous system, functioning on its own, with stretch receptors responsive to filling of the heart tha ...
Prophylactic Implantation of a Defibrillator in Patients with
... last follow-up visit were similar in the two treatment groups. During an average follow-up of 20 months, the mortality rates were 19.8 percent in the conventional-therapy group and 14.2 percent in the defibrillator group. The hazard ratio for the risk of death from any cause in the defibrillator gro ...
... last follow-up visit were similar in the two treatment groups. During an average follow-up of 20 months, the mortality rates were 19.8 percent in the conventional-therapy group and 14.2 percent in the defibrillator group. The hazard ratio for the risk of death from any cause in the defibrillator gro ...
Pak Heart J - Pakistan Heart Journal
... system after surgery in this region). Conversely, some conditions may warrant pacemaker implantation owing to the possibility of disease progression even if the AV block reverses transiently (eg, sarcoidosis, amyloidosis, neuromuscular diseases). Finally, permanent pacing for AV block after valve su ...
... system after surgery in this region). Conversely, some conditions may warrant pacemaker implantation owing to the possibility of disease progression even if the AV block reverses transiently (eg, sarcoidosis, amyloidosis, neuromuscular diseases). Finally, permanent pacing for AV block after valve su ...
Pericystic Fibrosis of a Cardiac Hydatid Cyst
... lack of inherent soft-tissue contrast, which limits its ability to depict regional differences in image intensity between normal and abnormal myocardium (8). MDCT also involves ionizing radiation and exposure to potentially nephrotoxic contrast agents. Cardiovascular MRI allows anatomic and function ...
... lack of inherent soft-tissue contrast, which limits its ability to depict regional differences in image intensity between normal and abnormal myocardium (8). MDCT also involves ionizing radiation and exposure to potentially nephrotoxic contrast agents. Cardiovascular MRI allows anatomic and function ...
Primary Prevention
... alone or in combination with cardiac resynchronization therapy with either a pacemaker (CRT-P) or pacemaker-defibrillator (CRT-D) • Both device arms significantly ↓ combined risk of all-cause hospitalization and all-cause mortality by ~20% compared with ...
... alone or in combination with cardiac resynchronization therapy with either a pacemaker (CRT-P) or pacemaker-defibrillator (CRT-D) • Both device arms significantly ↓ combined risk of all-cause hospitalization and all-cause mortality by ~20% compared with ...
Dynamics of oxidative stress and immune inflammation in chronic
... IIIFC (LVEF<40%) indicates a depletion of antioxidant defense. Dynamics of immune inflammation processes and oxidative stress depending on the severity of CHF and availability of reliable positive correlation between the markers indicates the existence of close links between the specified processes. ...
... IIIFC (LVEF<40%) indicates a depletion of antioxidant defense. Dynamics of immune inflammation processes and oxidative stress depending on the severity of CHF and availability of reliable positive correlation between the markers indicates the existence of close links between the specified processes. ...
Off-pump complete myocardia revascularization in low
... been statistically analysed with Standard Deviation and Confidence Limits. The definitive value of these data, although promising in terms of improvement, has to be validated with long term results. Conclusions : off-pump complete total arterial myocardial revascularisation in LVEF patients can be a ...
... been statistically analysed with Standard Deviation and Confidence Limits. The definitive value of these data, although promising in terms of improvement, has to be validated with long term results. Conclusions : off-pump complete total arterial myocardial revascularisation in LVEF patients can be a ...
The 12 lead ECG Some General Facts General lead placement
... activity recorded from 10 electrodes placed in standard positions on the body surface. Analogy- Envision the heart as an object placed on a pedestal around which a person can move while taking photographs (different views) from all angles. See skeleton with heart inside. ...
... activity recorded from 10 electrodes placed in standard positions on the body surface. Analogy- Envision the heart as an object placed on a pedestal around which a person can move while taking photographs (different views) from all angles. See skeleton with heart inside. ...
PDF - Asia Oceania Journal of Nuclear Medicine and Biology
... therapy in a patient with doxorubicin-induced cardiomyopathy (Figure 4). 99mTc-MIBI could monitor the change of mitochondrial damage induced by chemotherapy in asymptomatic patients with possible anthracycline antibiotic cardiotoxicity, although there is no difference in SPECT imaging before and aft ...
... therapy in a patient with doxorubicin-induced cardiomyopathy (Figure 4). 99mTc-MIBI could monitor the change of mitochondrial damage induced by chemotherapy in asymptomatic patients with possible anthracycline antibiotic cardiotoxicity, although there is no difference in SPECT imaging before and aft ...
Detection and Management of Fever and Infection in the
... infection (IL-6, TNF-α) and less response in viral infection • Initial studies suggested as method to guide diagnose infection • Suggestions that it is better discriminator than CRP ...
... infection (IL-6, TNF-α) and less response in viral infection • Initial studies suggested as method to guide diagnose infection • Suggestions that it is better discriminator than CRP ...
Role of atrioventricular nodal ablation and pacemaker therapy in
... who are receiving optimal recommended medical therapy and who have frequent dependence on ventricular pacing [33] ; CRT may be considered for patients with LV ejection fraction ≤35% with NYHA functional class I or II symptoms who are receiving optimal recommended medical therapy and who are under ...
... who are receiving optimal recommended medical therapy and who have frequent dependence on ventricular pacing [33] ; CRT may be considered for patients with LV ejection fraction ≤35% with NYHA functional class I or II symptoms who are receiving optimal recommended medical therapy and who are under ...
Tachyarrhythmias - patient information
... During the internal cardioversion, you will be given a short acting sedative to make you sleepy. Internal cardioversion is performed when medications and external cardioversion have been unsuccessful in returning the heart’s rhythm back to a normal sinus rhythm. Implantable cardioverter defibrillato ...
... During the internal cardioversion, you will be given a short acting sedative to make you sleepy. Internal cardioversion is performed when medications and external cardioversion have been unsuccessful in returning the heart’s rhythm back to a normal sinus rhythm. Implantable cardioverter defibrillato ...
Images and Case Reports in Interventional Cardiology
... significantly reduced, and tolerance to general physical activity was nearly normal (confirmed by treadmill exercise stress test). Control echocardiography and CT showed significant reduction of the tumor size and enlargement of the RV ...
... significantly reduced, and tolerance to general physical activity was nearly normal (confirmed by treadmill exercise stress test). Control echocardiography and CT showed significant reduction of the tumor size and enlargement of the RV ...
Recent Advances in Pacing and Defibrillation Harish Doppalapudi
... rhythm. People who have survived a cardiac arrest or who are at high risk for developing one would benefit from placement of devices called implantable cardioverter defibrillators (ICDs), which can continuously monitor the patient’s rhythm, rapidly detect any lethal ventricular rhythm that occurs, a ...
... rhythm. People who have survived a cardiac arrest or who are at high risk for developing one would benefit from placement of devices called implantable cardioverter defibrillators (ICDs), which can continuously monitor the patient’s rhythm, rapidly detect any lethal ventricular rhythm that occurs, a ...
Heart Physiology
... • Epinephrine from adrenal medulla increases heart rate and force of contraction. • Hypocalcemia (reduced calcium) reduces heart activity • Hypercalcemia (increased calcium) couples excitationcontraction and leads to prolonged action potential and increase heart irritabilitiy (spastic contractions) ...
... • Epinephrine from adrenal medulla increases heart rate and force of contraction. • Hypocalcemia (reduced calcium) reduces heart activity • Hypercalcemia (increased calcium) couples excitationcontraction and leads to prolonged action potential and increase heart irritabilitiy (spastic contractions) ...
Accessory pathways during normal and abnormal cardiac
... • Majority no familial involvement, • Pathogenesis unknown • Minority of cases are inherited as single gene disorder: PRKAG2 gene mutation,others ...
... • Majority no familial involvement, • Pathogenesis unknown • Minority of cases are inherited as single gene disorder: PRKAG2 gene mutation,others ...
Cardiac contractility modulation
.jpg?width=300)
Cardiac contractility modulation (CCM) is a treatment for patients with moderate to severe left ventricular systolic heart failure (NYHA class II–IV). The short- and long-term use of this therapy enhances both the strength of ventricular contraction and the heart’s pumping capacity. The CCM mechanism is based on stimulation of the cardiac muscle by non-excitatory electrical signals (NES). CCM treatment is delivered by a pacemaker-like device that applies the NES, adjusted to and synchronized with the electrical action in the cardiac cycle.In CCM therapy, electrical stimulation is applied to the cardiac muscle during the absolute refractory period. In this phase of the cardiac cycle, electrical signals cannot trigger new cardiac muscle contractions, hence this type of stimulation is known as a non-excitatory stimulation. However, the electrical CCM signals increase the influx of calcium ions into the cardiac muscle cells (cardiomyocytes). In contrast to other electrical stimulation treatments for heart failure, such as pacemaker therapy or implantable cardioverter defibrillators (ICD), CCM does not affect the cardiac rhythm directly. Rather, the aim is to enhance the heart’s natural contraction (the native cardiac contractility) sustainably over long periods of time. Furthermore, unlike most interventions that increase cardiac contractility, CCM is not associated with an unfavorable increase in oxygen demand by the heart (measured in terms of Myocardial Oxygen Consumption or MVO2). This may be explained by the beneficial effect CCM has in improving cardiac efficiency. A meta-analysis in 2014 and an overview of device-based treatment options in heart failure in 2013 concluded that CCM treatment is safe, that it is generally beneficial to patients and that CCM treatment increases the exercise tolerance (ET) and quality of life (QoL) of patients. Furthermore, preliminary long-term survival data shows that CCM is associated with lower long-term mortality in heart failure patients when compared with expected rates among similar patients not treated with CCM.